Software Development Engineer Intern
Boston Scientific5 days ago
Waltham, MA, USAIntern
Base Salary
$45k - $76k/yr
Responsibilities
- Design, develop, and unit test software applications using C++ in a Linux environment.
- Participate in Agile scrum teams to coordinate feature development and resolve technical issues.
- Collaborate with software development, testing, and other cross-functional teams throughout the development lifecycle.
- Contribute to user interface, algorithm development, and back-end data handling components.
- Apply problem-solving skills to deliver high-quality and reliable software solutions.
- Develop technical capabilities through mentorship, hands-on work, and continuous learning.
Requirements
- Currently pursue a bachelor’s or graduate-level degree in Computer Science, Biomedical Engineering, or Electrical Engineering, with expected graduation in fall/winter 2027 or spring 2028.
- Demonstrate programming proficiency in C, C++, or Rust.
- Understand object-oriented programming principles.
- Be available for the full internship duration from either May 17-August 6 or May 24-August 13, 2027.
- Be eligible to work in the U.S. without company sponsorship now or in the future for employment-based work authorization.
- Have reliable transportation to the Waltham, Massachusetts office.
- Preferred qualifications include systems-level programming, Linux, Qt, strong communication and documentation skills, attention to detail, adaptability, and the ability to work independently and collaboratively.
Benefits
- Hybrid work model requiring at least four days per week in the local office.
- Relocation assistance may be available to eligible candidates.
- Internship program dates are May 17-August 6 or May 24-August 13, 2027.
- Boston Scientific does not provide transportation or transportation support to and from the office.
About Boston Scientific
Boston Scientific designs and manufactures implantable and minimally invasive medical devices used by physicians to diagnose and treat cardiovascular, endoscopic, urological, neurological, and other conditions. It sells these products and related therapies to hospitals and health systems worldwide through a direct sales model and distributors. Founded in 1979 and headquartered in Marlborough, Massachusetts, it is publicly traded on the NYSE (BSX) with offerings spanning stents, catheters, electrophysiology, and neuromodulation systems.